Elevated miR-21 is associated with poor prognosis in non-small cell lung cancer: a systematic review and meta-analysis.
CONCLUSIONS: Our meta-analysis suggested that miR-21 may function as an unfavorable biomarker of prognosis in NSCLC patients.
PMID: 30024605 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Databases & Libraries | Drugs & Pharmacology | Lung Cancer | Non-Small Cell Lung Cancer | Pathology | Science | Study